Ufp Technologies INC 8-K filings

UFP Technologies announced record-breaking second quarter financial results, driven by a 15.1% increase in net sales to $174.0 million and a 21.4% rise in net income to $20.9 million.

UFP Technologies announced the appointment of Ryan Stafford as General Counsel and Senior Vice President of Human Resources, effective June 4, 2026, succeeding the retiring Christopher P. Litterio.

UFP Technologies releases updated investor presentation highlighting its growth strategy and financial performance in the medical device manufacturing sector.

UFP Technologies, Inc. successfully concluded its 2026 Annual Meeting of Stockholders, confirming the election of seven directors and the ratification of its independent auditor.

UFP Technologies announces the planned retirement of its General Counsel, Secretary, and Senior Vice President of Human Resources.

UFP Technologies announced first quarter 2026 financial results, with net income rising 1.8% to $17.5 million and net sales increasing 4.1% to $154.2 million, driven by medical device segment growth.

UFP Technologies, a leading medical device CDMO, presented updated investor materials highlighting its focus on high-growth MedTech segments and ambitious financial targets.

UFP Technologies, Inc. announced an amendment to its manufacturing supply agreement with Intuitive Surgical SARL, extending the term through 2029 and increasing minimum volumes.

UFP Technologies disclosed a cybersecurity incident detected on February 14, 2026, involving unauthorized access to its IT systems and data exfiltration.

UFP Technologies announced record net income and sales for 2025, driven by strong medical market growth and strategic expansions.

UFP Technologies announced the appointment of Mitchell C. Rock as its new CEO, effective June 4, 2026, alongside significant executive compensation adjustments and equity awards.

UFP Technologies provides an investor presentation highlighting its transformation into a MedTech-focused CDMO with strong growth and strategic acquisition plans.

UFP Technologies announces CEO R. Jeffrey Bailly's retirement and the appointment of Mitchell Rock, current President, effective June 4, 2026.

UFP Technologies announced Q3 2025 net income of $16.4 million and sales of $154.6 million, driven by MedTech growth despite temporary labor costs.

UFP Technologies, a CDMO specializing in medical devices, filed an updated investor presentation highlighting its strategic shift to MedTech, strong growth, and ambitious financial targets.

UFP Technologies announced record second-quarter 2025 financial results, with significant growth in sales and net income, primarily fueled by strategic acquisitions and strong performance in its MedTech segment.

UFP Technologies, Inc. has completed the acquisitions of UNIPEC and Techno Plastics Industries, Inc. (TPI), expanding its capabilities in tight tolerance film components and thermoplastic molding for the medical device market.

UFP Technologies, a leading contract development and manufacturing organization, released an updated investor presentation highlighting its strategic focus on high-growth medical device markets, robust acquisition strategy, and ambitious long-term financial targets.

UFP Technologies, Inc. announced the results of its Annual Meeting of Stockholders held on June 4, 2025, where all seven director nominees were elected, executive compensation was approved on an advisory basis, and Grant Thornton LLP was ratified as the independent auditor.

UFP Technologies announces record first-quarter results, with significant growth in revenue, operating income, and net income, primarily driven by its MedTech business.

UFP Technologies' subsidiary, AJR Enterprises, has entered into two supply agreements with Stryker, ensuring exclusive manufacturing rights for certain products.

Steve Cardin, Vice President and Chief Operating Officer of the MedTech business at UFP Technologies, has resigned, with his last day being March 28, 2025.

UFP Technologies announces record 2024 financial results, with net sales up 26.1% and net income increasing by 31.3%, fueled by strong performance in the MedTech sector and contributions from recent acquisitions.

UFP Technologies has increased base salaries and approved stock unit awards and cash bonus plans for its named executive officers effective January 1, 2025.

UFP Technologies announced a 40% increase in net income and a 44% increase in sales for the third quarter of 2024, driven by strong organic growth and successful acquisitions.

UFP Technologies presented updated investor materials highlighting their focus on MedTech, strategic acquisitions, and ambitious financial targets.

UFP Technologies has acquired AQF Medical for $43 million in cash, expanding its European and Asian manufacturing presence.

UFP Technologies announced record second-quarter results with a 10.1% increase in sales and a 14% increase in net income, fueled by growth in the medical sector and strategic acquisitions.

UFP Technologies has acquired Welch Fluorocarbon and Marble Medical, enhancing its capabilities in thin film thermoforming and adhesive-based medical components.

UFP Technologies has acquired AJR Enterprises, a medical device contract manufacturer specializing in safe patient handling systems, for $110 million.